Inventor · disambiguated record
Louis Habash
Also filed as: HABASH LOUIS
21 granted patents·17 pending applications·88 citations·filing 2004–2024
94Inventor score
Top patents by PatentIndex Score
38 records- 0196US11324737B1Modulating expression level of a gene encoding a heat shock protein by treating a human subject with a nitroxideHABASH LOUIS·Filed 2021·Granted May 10, 2022·6 cites·12 claims
- 0294US9545398B1Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxideHABASH LOUIS·Filed 2016·Granted Jan 17, 2017·9 cites·5 claims
- 0393US11510913B1Modulating expression level of a gene encoding an apurinic/apyrimidinic endodeoxyribonuclease protein by treating a human subject with a nitroxideHABASH LOUIS·Filed 2021·Granted Nov 29, 2022·3 cites·11 claims
- 0493US10874654B2Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxideHABASH LOUIS·Filed 2019·Granted Dec 29, 2020·5 cites·9 claims
- 0593US10441578B2Altering expression level of glutathione S-transferase genes by treating a human subject with a nitroxideHABASH LOUIS·Filed 2018·Granted Oct 15, 2019·6 cites·23 claims
- 0693US10231959B2Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxideHABASH LOUIS·Filed 2016·Granted Mar 19, 2019·5 cites·20 claims
- 0793US9700550B1Decreasing expression level of apoptosis-related genes by treating a human subject with a nitroxideHABASH LOUIS·Filed 2017·Granted Jul 11, 2017·7 cites·12 claims
- 0893US9579311B1Decreasing expression level of apoptosis-related genes by treating a human subject with a nitroxideHABASH LOUIS·Filed 2016·Granted Feb 28, 2017·10 cites·4 claims
- 0991US10064852B2Decreasing expression level of apoptosis-related genes by treating a human subject with a nitroxideHABASH LOUIS·Filed 2017·Granted Sep 4, 2018·5 cites·30 claims
- 1091US8563581B2Nitroxides for use in treating predisposed or at risk patientsHABASH LOUIS·Filed 2006·Granted Oct 22, 2013·9 cites·21 claims
- 1187US9522143B2Nitroxides for use in treating or preventing diabetes and obesityMITOS PHARMACEUTICALS INC·Filed 2015·Granted Dec 20, 2016·3 cites·34 claims
- 1287US9101619B2Nitroxides for use in treating or preventing diabetes and obesityMITOS PHARMACEUTICALS INC·Filed 2013·Granted Aug 11, 2015·10 cites·25 claims
- 1385US10159665B2Preventing amyloid plaque formation by treating a human subject with a nitroxideHABASH LOUIS·Filed 2017·Granted Dec 25, 2018·2 cites·4 claims
- 1485US9744162B1Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxideHABASH LOUIS·Filed 2016·Granted Aug 29, 2017·2 cites·23 claims
- 1585US9522144B2Nitroxides for use in treating or preventing diabetes and obesityMITOS PHARMACEUTICALS INC·Filed 2015·Granted Dec 20, 2016·2 cites·12 claims
- 1679US10828291B2Decreasing expression level of proteasome subunit genes by treating a human subject with a nitroxideHABASH LOUIS·Filed 2018·Granted Nov 10, 2020·2 cites·17 claims
- 1779US10245256B2Nitroxides for use in treating or preventing diabetes and obesityMITOS PHARMACEUTICALS INC·Filed 2016·Granted Apr 2, 2019·2 cites·15 claims
- 1877US2024415826A1Modulating expression level of a gene encoding an uncoupling protein by treating a human subject with a nitroxideHABASH LOUIS·Filed 2024·Application pending·0 cites
- 1974US2025041285A1Modifying the expression level of a gene encoding an cyclooxygenase enzyme by treating a human subject with a nitroxideHABASH LOUIS·Filed 2024·Application pending·0 cites
- 2071US11839606B2Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxideHABASH LOUIS·Filed 2020·Granted Dec 12, 2023·0 cites·18 claims
- 2171US2024325368A1Modulating expression level of a gene encoding a heat shock protein by treating a human subject with a nitroxideHABASH LOUIS·Filed 2023·Application pending·0 cites
- 2266US11998536B2Decreasing expression level of proteasome subunit genes by treating a human subject with a nitroxideHABASH LOUIS·Filed 2020·Granted Jun 4, 2024·0 cites·10 claims
- 2364US2022378767A1Modulating expression level of a gene encoding an uncoupling protein by treating a human subject with a nitroxideHABASH LOUIS·Filed 2021·Application pending·0 cites
- 2464US2022378771A1Modifying the expression level of a gene encoding an cyclooxygenase enzyme by treating a human subject with a nitroxideHABASH LOUIS·Filed 2021·Application pending·0 cites
- 2564US2020171011A1Altering expression level of glutathione s-transferase genes by treating a human subject with a nitroxideHABASH LOUIS·Filed 2019·Application pending·0 cites
- 2663US11819500B2T-cell regulation in t-cell mediated diseases by reducing pathogenic function of TH17 in a human subject through treatment with a nitroxideHABASH LOUIS·Filed 2020·Granted Nov 21, 2023·0 cites·24 claims
- 2758US2018078539A1T-cell regulation in t-cell mediated diseases by reducing pathogenic function of th17 in a human subject through treatment with a nitroxideHABASH LOUIS·Filed 2017·Application pending·0 cites
- 2857US12208089B2Adjusting expression level of a gene encoding a Sirtuin protein by treating a human subject with a nitroxideHABASH LOUIS·Filed 2021·Granted Jan 28, 2025·0 cites·14 claims
- 2956US2022378764A1Modulating expression level of a gene encoding a cytochrome p450 protein by treating a human subject with a nitroxideHABASH LOUIS·Filed 2021·Application pending·0 cites
- 3056US2022378766A1Modulating expression level of a gene encoding an uncoupling protein by treating a human subject with a nitroxideHABASH LOUIS·Filed 2021·Application pending·0 cites
- 3149US2007010506A1Methods of using nitroxides in conjuction with photosensitzers and sonosensitizersCHANG KENNETH·Filed 2004·Application pending·0 cites
- 3247US2018078538A1Method of treating a human subject having a desmosome associated disorder by administering a nitroxideHABASH LOUIS·Filed 2017·Application pending·0 cites
- 3345US2010041716A1Nitroxides for use in treating or preventing hypercholesterolemiaMITOS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3443US2010241197A1Methods of using nitroxides in conjunction with photosensitizers and sonosensitizersMITOS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3541US2012046314A1Nitroxides for use in treating or preventing neoplastic diseaseHABASH LOUIS·Filed 2006·Application pending·0 cites
- 3641US2009042937A1Nitroxides for use in treating or preventing amyloid-related diseasesHABASH LOUIS·Filed 2006·Application pending·0 cites
- 3741US2009209581A1Nitroxides for use in treating or preventing immunological diseasesHABASH LOUIS·Filed 2006·Application pending·0 cites
- 3841US2009062338A1Nitroxides for use in treating or preventing cardiovascular diseaseHABASH LOUIS·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Louis Habash files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →